Abstract.-The molecular and chemical characteristics of membrane components bearing the major transplantation antigen systems in mouse (H-2) and man (HL-A) were compared and found to be strikingly similar.
The major system of human transplantation antigens (HL-A), appear similar in many respects to the major histocompatibility antigens of the mouse (H-2). In both species, these transplantation antigens consist of a group of cell membrane-associated determinants that can be detected by serologic techniques. Present evidence indicates that both the H-2 and HL-A antigens are controlled by a single compact genetic region.1 2 Human clinical studies3 and animal experiments1 have shown these alloantigenic determinants to be responsible for the immunologic response that leads to the rejection of allografted tissue in their respective species.
The genetic similarities, as well as the biological or functional similarities, of the H-2 and HL-A alloantigens raises the question as to whether similarities also exist at the molecular level. To pursue this question, direct comparison of the solubization, chromatographic, and electrophoretic characteristics of H-2 and HL-A alloantigenic materials were made. The results of these studies, as well as comparisons of the over-all chemical properties of purified mouse and human transplantation antigens, are reported in this communication.
Methods and Materials.-Sources: In this study mouse spleen cells and human lymphoid tissue culture cells were used as source materials for direct comparisons. In independent studies4, 5 no essential differences have been found in the characteristics of alloantigenic materials when tissue cultured cells or spleen cells were used as source materials. Crude cell membranes were prepared from these sources. This procedure as well as the methods of solubilization and purification of separate H-24 and HL-A5 alloantigenic ma-terials are detailed elsewhere. The methods, using a combination of these materials, are summarized as follows.
Solubilization: Membrane preparations from the source materials were suspended in 0.14 AI saline buffered to a pH of 8.6 with 0.01 f11 Tris-HCl and treated with the enzyme papain. In order to determine the rate of release of the H-2 and HL-A alloantigens, the membrane preparations were exposed to papain for periods of 0, 15, 30, 60, and 90 min.
The enzymatic reaction was stopped with iodoacetate in quantities to achieve a final concentration of 0.01 M. The insoluble component of these digestion mixtures was removed by centrifugation for 1 hr at 100,000 X g in a Spinco model L-2 centrifuge (40 rotor). The supernatants, as well as the insoluble components, were recovered and assayed for the H-2 and HL-A alloantigenic activity.
Assay methods: Mouse H-2 alloantigens were detected by inhibition of immune cytolysis. Two antiserums were used. One antiserum was raised by injecting EL-4 tumor cells (from C57B1 /6) into B1OD2 mice and could theoretically contain antibodies against H-2.2, H-2.5, H-2.22, and H-2.33 determinants if tested against C57B1/6 cells. In order to detect H-2.5 alone, the antiserum was tested against D1OBR cells. The other antisera detected H-2.2 only when tested against C57B1/6 and was obtained from the H-2 serum bank of the Transplantation Immunology Branch, NIAID.
HL-A alloantigens were detected in a similar type cytotoxic inhibition assay system using the human leukocyte typing antisera obtained from the Transplantation Immunology Branch, NIAID. Alloantigenic activity was assessed by the ability of the various preparations to inhibit the immune cytolysis of human lymphoid target cells by these antiserums.
Gel filtration: Solubilized materials containing H-2 and HL-A alloantigens were concentrated and placed on a 0.9 cm X 100 cm columns of Sephadex G-150. The columns were eluted with a 0.14 M NaCl solution buffered to a pH of 8.6 with 0.01 Ml Tris-HCl. Volumes of 2 ml were collected. The protein concentration of the eluted solution was determined by absorbent measurements at 280 m/u and the individual elution fractions assayed for H-2 and/or HL-A allogenic activity in the cytotoxic inhibition assays.
Disk-gel electrophoresis: The fractions from the gel filtration containing the H-2 and HL-A alloantigenic materials were pooled and concentrated. Volumes of 200 ul, containing 300 ,ug protein, were layered on 7.5% acrylamide gels in 0.8 cm X 12 cm tubes using a 1 cm stacking gel. Electrophoresis was performed at 2.5 milliamps per tube with a running buffer of 0.1 Al Tris-HCl in 0.3 ll glycine (diluted 1:5) at a pH of 8.3 . After 3 hr, the electrophoresis was stopped and the individual gels were removed from the tubes and cut into 0.5-cm sections. Each section was eluted with 0.5 ml of a 0.1 Al Tris-HCl buffered saline (0.14 111) solution. The eluates were tested for H-2 and HL-A alloantigenic activity.
Amino acid composition: The amino acid composition of H-2 and HL-A alloantigenic materials was determined on individual preparations from mouse and human lymphoid cells.
Two lymphoid cell sources (RAJI, R-4265) with differing HL-A antigenic determinants were prepared individually by the methods described elsewhere.5 The purified materials were then hydrolyzed for 24 hr for 6 N HCl at 110°C in sealed tubes flushed with N2.
H-2 alloantigenic bearing materials from C57B1/6 and DBA/2 were prepared individually by papain solubilization, G-150 Sephadex chromatography, DEAE Sephadex, and acrylamide gel electrophoresis as described in a previous report.4 The amino acid composition of this material was determined after hydrolysis with 6 N HCl for 24 hr at 1 10°C in sealed tubes flushed with N2. Amino acid analysis was performed with a Beckman automatic amino acid analyzer.
Carbohydrate composition: H-2 and HL-A alloantigenic materials were assayed for neutral sugars, sialic acid, and amino sugars. Mannose was used as a standard in the method to detect neutral sugars;6 N-acetyl neuraminic acid was the standard for the determination of sialic acid content,7 and glucosamine used as a standard for the determination of amino sugars.8
Results.-Solubilization: The solubilization characteristics of H-2 and HL-A alloantigenic materials from their respective membrane sources are compared in Figure 1 . The H-2b antigenic activity was determined in the cytotoxic inhibition assay using an antiserum which detected the H-2.2, H-2.5, H-2.22 and H-2.33 determinants, The human alloantigenic activity was assessed using a lymphocyte typing antiserum which detected the LA-3 specificity. Both the H-2 and HL-A alloantigenic activity disappeared from the membrane preparations with increasing periods of time of exposure to papain. The maximum amount of both H-2 and HL-A alloantigenic activity in soluble form was found after 60 min of incubation.
Chromatographic characteristics: The chromatographic characteristics of the mixed H-2 and HL-A alloantigenic materials in soluble form are shown in Figure  2 . The H-2 and HL-A antigenic activity, assessed in the cytotoxic inhibition assays, was found to elute in similar volumes from the G-150 Sephadex. Maximum recovery of the H-2.5 activity was found in tube 48 while the H-2.2, H-2.22 activity was recovered in a peak of maximum inhibition at tube 57, well separated from the H-2.5 specificity. Separation of the specificities was also noted when the HL-A antigenic activity was determined. The two specificities 6b and 7c were found in maximum concentration in tube 47 and was separated from the LA-4 activity which eluted in maximum concentration in tube 57. Separate G-150 Sephadex preparations of H-2 and HL-A alloantigenic materials were tested for possible cross-reactivity. Mouse H-2 alloantigenic materials did not inhibit the cytotoxic activity of the human HL-A antiserums and, likewise, HL-A alloantigenic materials did not inhibit the H-2 specificities H-2.5 and H-2.2, H-2.22.
Electrophoretic mobility on acrylamide gels: The alloantigenic activity of materials eluted from acrylamide gels is shown in Figure 3 . The H-2.5 specificity was detected at maximum concentration 4 cm from the origin while the HL-A specificities 6b and 7c were detected at approximately 4.5 cm from the origin. Papain-released fragments bearing these specificities are approximately the same size as can be seen in the elution patterns rom the G-150 Sephadex chromatography (mol wt approx 66,000 for H-2.5).4 Further studies have shown the H-2 alloantigenic materials to have an isoelectric point of 5.2 and HL-A alloantigenic materials are shown to have an isoelectric point of 4.35 (unpublished observations). This difference most probably accounts for the differences in the electrophoretic mobility of these materials on the acrylamide gels.
Carbohydrate composition: Table 1 compares the carbohydrate composition of the H-2 and HL-A alloantigenic materials purified by the methods described. The greatest difference was seen in the glucosamine content which was less than 0.05 per cent in the HL-A materials and in the order of 5 per cent in H-2b materials and 3 per cent in the H-2d bearing materials. Neutral sugar composition of the The participation of the carbohydrate residues and protein in conferring the H-2 or the HL-A alloantigenic specificities has not been delineated at this time. Treatment of both the mouse and hyman alloantigenic materials isolated by papain digestion with protein denaturing agents such as urea, heat, and sodium deodecyl sulfate as well as with proteolytic enzymes have demonstrated an obliteration of antigenic activity.4' 5 This evidence would indicate that the integrity of the protein molecule is necessary for the expression of the respective antigenic determinants from these animal species but does not exclude the possibility that a protein-carbohydrate complex serves as a site for specificity.
Amino acid composition: Figure 4 compares graphically the amino acid composition of the HL-A and H-2 alloantigenic materials. The results are expressed as the average moles per cent of the total amino acid residues recovered in two determinations from each source. The sources of HL-A alloantigenic materials were two human lymphoid cell lines (RAJJ, R-4265) which contain different HL-A alloantigenic determinants. The H-2 alloantigenic preparations were from the C57B1/6 mice and from DBA/2 mice which carry the H-2b and H-2d alleles, respectively. Differences in the amino acid composition were found, however, the general pattern of distribution is quite similar.
A method for assessing the compositional relatedness of proteins has been reported by Metzgar.9 Proteins are compared by calculating a difference index based on the amino acid composition of each. Two proteins with no amino acids in common would have a difference index of 100 while two proteins with the same composition would have a difference index of 0. Table 2 shows the difference index of the two proteins bearing the HL-A alloantigens and the proteins bearing the DBA/2 and C57B1/6 alloantigenic determinants, as well as the difference index of mouse immunoglobulin light chains'0 and human immunoglobulin light chains." The difference index of the two different HL-A alloantigenic materials and the two different H-2 materials was quite similar (2.5 and 3.5). A comparison of the HL-A and H-2 materials reveals that the difference index ranged from 11 to 13 and was similar to the comparison of mouse and human immunoglobulin light chains. When the difference index of the HL-A and H-2 alloantigenic material was compared to the immunoglobulin light chains from these two species, higher values were obtained. Discussion.-Previous studies of mouse and human transplantation antigens indicated many similarities. The enzymatic techniques introduced by Nathenson and Davies,"2 in order to solubilize the mouse H-2 alloantigens, were shown to be applicable to the solubilization of human HL-A alloantigens.13-15 This report documents, by direct comparisons, many similarities in the physical and chemical characteristics of solubilized human and mouse transplantation antigens.
Similar physical properties are shown in the gel filtration and electrophoretic. studies. Both the mouse and human alloantigenic materials, solubilized by papain treatment, exist in two major forms which differ in size and carry a different series of alloantigens.'6' 17 The existence of two forms, each with its own characteristic group of genetically determined transplantation antigens, is thought to indicate that two (or more) gene cistrons may exist in the gene locus for the transplantation antigen system, i.e. one cistron for each category of molecule.'6 This molecular evidence is in accordance with genetic evidence for a number of subdivisions in the mouse H-2 and human HL-A genetic regions.
Chemical similarities of these materials are demonstrated in the comparison of carbohydrate content and in the distribution of amino acid residues of the purified H-2 and HL-A alloantigenic materials. The amino acid composition of the mouse and human transplantation antigens is quite similar to the reported composition of the guinea pig transplantation antigen solubilized by sonication. "I Transplantation-antigen preparations from mouse and man were compared with each other and with immunoglobulin light chains from both species by using the difference index technique (Table 2) . Clearly, as summarized in Table 3 , histocompatibility-antigen preparations within species have a high degree of similarity and relatedness as shown by the very low difference index, i.e., under 5. They would not be expected to be identical because preparations from different strains of mice or from different persons (i.e., the different human cell lines) have distinctive patterns of antigenic specificities. The low difference index, however, indicates close over-all compositional relatedness within the species.
Comparison of different categories of substances (i.e., transplantation antigen versus light chains) whether within or between species yield difference index values greater than 15 ( Amino acid sequence analysis of immunoglobulin light chains from a number of animal species have shown a series of common regions. '9 This evidence has led to the hypothesis that these proteins evolved from a common ancestral gene. Comparisons of light chains and transplantation antigens between species shows similar levels of amino acid relatedness (i.e., difference index). The compositional similarities in the materials bearing the transplantation antigens suggest that these cell membrane components might also have evolved from a common ancestral gene. This hypothesis is being explored with more detailed biochemical studies.
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